Menu
/REGISTER
Montecito
Nixon Peabody
Pac Premier
Loading...
You are here:  Home  >  'Prolia'
Latest

Life sciences venture fund has confidence in region

By   /  Friday, September 7th, 2018  /  Latest news, Technology  /  Comments Off on Life sciences venture fund has confidence in region

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

New drugs boost profits at Amgen as two executives leave company

By   /  Friday, August 3rd, 2018  /  Central Coast Health Watch, Earnings, East Ventura County, left, Tri-County Public Companies  /  Comments Off on New drugs boost profits at Amgen as two executives leave company

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen earnings per share up 20 percent due to higher product sales

By   /  Thursday, July 26th, 2018  /  Central Coast Health Watch, Earnings, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen earnings per share up 20 percent due to higher product sales

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen drugs Kyprolis and Prolia gain approvals

By   /  Monday, June 11th, 2018  /  Central Coast Health Watch, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen drugs Kyprolis and Prolia gain approvals

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Drug sales for biotech giant Amgen boost bottom line

By   /  Friday, February 10th, 2017  /  Central Coast Health Watch, Earnings, left, Technology, Tri-County Public Companies  /  Comments Off on Drug sales for biotech giant Amgen boost bottom line

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen reports positive results for Prolia

By   /  Monday, August 29th, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen reports positive results for Prolia

Thousand Oaks-based biotech giant Amgen announced positive results from patients receiving Prolia to treat inflammation Aug. 29. In the study, Prolia, normally used to treat osteoporosis, hypercalcemia and bone cancer, was used to treat inflammation. The two-year study enrolled 795 patients to evaluate the safety of two 60 milligram doses of Prolia given under the Read More →

Read More →
Latest

Amgen reports revenue increase in second quarter earnings

By   /  Wednesday, July 27th, 2016  /  Central Coast Health Watch, Earnings, Latest news, Tri-County Public Companies, West Ventura County  /  Comments Off on Amgen reports revenue increase in second quarter earnings

Updated on July 27 at 4 p.m.: Amgen reported a 6 percent increase in revenue and a 15 percent increase in earnings per share in its second quarter earnings released July 27. Revenues grew to $5.7 billion due to higher sales of the company’s drugs Enbrel, Prolia, Kyprolis and Xgeva, and operating income increased 15 Read More →

Read More →